STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB)

CUSIP: 34385P108

Q3 2018 13F Holders as of 30 Sep 2018

Holder snapshot 7 signals
Share change
+808,005
Put/Call ratio
53%
SEC-reported price per share
$7.49
Number of holders
79
Value change
+$6,429,245
Number of buys
40
Open additional details 1 more signal available
Number of sells
33
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
391,007,800

Security key

34385P108

Report period

Q3 2018

Institutions

79

Top holders

10

Ownership snapshot

Top reported holders of LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
LEVIN CAPITAL STRATEGIES,...
Disclosed value leader
LEVIN CAPITAL STRATEGIES,...
Comparable rows
15/15
Latest evidence
30 Jun 2018
13F Lead comparable stake: 2.6% Showing 1-6 of 15 holder rows.

Quick read

LEVIN CAPITAL STRATEGIES, L.P. leads the comparable SEC ownership view at 2.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens LEVIN CAPITAL STRATEGIES, L.P.'s linked filing trail.
Comparable ownership Top 5
LEVIN CAPITAL STRATEGIES, L.P. 2.6%
PRIMECAP MANAGEMENT CO/CA/ 1.5%
Neuberger Berman Group LLC 1.2%
Russell Investments Group, Ltd. 1.1%
BlackRock Finance, Inc. 0.51%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
LEVIN CAPITAL STRATEGIES, L.P.
13F
Company
13F
2.6%
$60,842,000
10,208,322 shares
30 Jun 2018
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
1.5%
$34,521,000
5,792,043 shares
30 Jun 2018
Neuberger Berman Group LLC
13F
Company
13F
1.2%
$26,883,000
4,510,994 shares
30 Jun 2018
Russell Investments Group, Ltd.
13F
Company
13F
1.1%
$26,180,000
4,394,950 shares
30 Jun 2018
BlackRock Finance, Inc.
13F
Company
13F
0.51%
$11,922,000
2,000,281 shares
30 Jun 2018
ORBIMED ADVISORS LLC
13F
Company
13F
0.41%
$9,439,000
1,583,700 shares
30 Jun 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
79
Shares
38,859,260
Rows available
79
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders
83
Q3 2018 holders
79
Holder diff
-4
Investor Q2 2018 Shares Q3 2018 Shares Share Diff Share Chg % Q2 2018 value Q3 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .